• Product NameOLFM4 Antibody FITC Conjugated
• Host SpeciesRabbit
• ClonalityPolyclonal
• IsotypeIgG
• PurificationPurified by Protein A.
• Applications IF
• Species ReactivityHu Ms Rt
• Immunogen DescriptionKLH conjugated synthetic peptide aa 130-160 510 derived from human OLFM4
• ConjugatesFITC
• Excitation Emission494nm 518nm
• Target NameOLFM4
• Alternative Names    GC1; OLM4; OlfD; GW112; hGC-1; hOLfD; UNQ362; bA209J19.1; Olfactomedin-4; Antiapoptotic protein GW112; G-CSF-stimulated clone 1 protein; OLFM4; UNQ362 PRO698
• Accession No. Swiss-Prot#Q6UX06
  NCBI Gene ID10562
• UniprotQ6UX06
• Gene ID10562;
• Concentration 1mg ml
• Formulation 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
• Storage Shipped at 4˚C. Store at -20˚C for one year. Avoid repeated freeze/thaw cycles.

• IF=1:50-200

May promote proliferation of pancreatic cancer cells by favoring the transition from the S to G2 M phase. In myeloid leukemic cell lines, inhibits cell growth and induces cell differentiation and apoptosis. May play a role in the inhibition of EIF4EBP1 phosphorylation deactivation. Facilitates cell adhesion, most probably through interaction with cell surface lectins and cadherin.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting